Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease

ClinicalTrials.gov ID: NCT00562887

Public ClinicalTrials.gov record NCT00562887. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2B, Multi-Center, Randomized, Double-blind, Parallel Group, Placebo-controlled, Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs. Placebo in Subjects With Moderately to Severely Active Crohn's Disease.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the efficacy, safety and pharmacokinetics of ABT-874 to placebo in subjects who have moderately to severely active Crohn's Disease.

Study identification

NCT ID
NCT00562887
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Abbott
Industry
Enrollment
246 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 74 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2007
Primary completion
Mar 31, 2010
Completion
Not listed
Last update posted
Aug 22, 2011

Started 2007

United States locations

U.S. sites
36
U.S. states
19
U.S. cities
33
Facility City State ZIP Site status
Site Ref # / Investigator 6792 Orange California 92868
Site Ref # / Investigator 6643 San Diego California 92123
Site Ref # / Investigator 6670 Hamden Connecticut 06518
Site Ref # / Investigator 6694 Gainesville Florida 32610
Site Ref # / Investigator 6794 Jacksonville Florida 32256
Site Ref # / Investigator 6687 Winter Park Florida 32789
Site Ref # / Investigator 6667 Zephyrhills Florida 33542
Site Ref # / Investigator 6691 Atlanta Georgia 30308
Site Ref # / Investigator 6642 Atlanta Georgia 30342
Site Ref # / Investigator 8797 Macon Georgia 31201
Site Ref # / Investigator 6925 Baton Rouge Louisiana 70809
Site Ref # / Investigator 6865 Chevy Chase Maryland 20815
Site Ref # / Investigator 10202 Towson Maryland 21204
Site Ref # / Investigator 6866 Rochester Minnesota 55905
Site Ref # / Investigator 6778 Mexico Missouri 65265
Site Ref # / Investigator 7048 St Louis Missouri 63110
Site Ref # / Investigator 7952 Las Vegas Nevada 89128
Site Ref # / Investigator 6647 Cedar Knolls New Jersey 07927
Site Ref # / Investigator 6689 Great Neck New York 11021
Site Ref # / Investigator 6652 Lake Success New York 11042
Site Ref # / Investigator 7047 New York New York 10029
Site Ref # / Investigator 6693 Asheville North Carolina 28801
Site Ref # / Investigator 6785 Charlotte North Carolina 28207
Site Ref # / Investigator 9070 Morgantown North Carolina 28655
Site Ref # / Investigator 6651 Raleigh North Carolina 27612
Site Ref # / Investigator 6665 Beachwood Ohio 44122
Site Ref # / Investigator 6690 Cincinnati Ohio 45219
Site Ref # / Investigator 6786 Portland Oregon 97220
Site Ref # / Investigator 7004 Germantown Tennessee 38138
Site Ref # / Investigator 6648 Nashville Tennessee 37203
Site Ref # / Investigator 6793 Nashville Tennessee 37205
Site Ref # / Investigator 7054 Nashville Tennessee 37212-1610
Site Ref # / Investigator 8357 Round Rock Texas 78681
Site Ref # / Investigator 6688 Ogden Utah 84405
Site Ref # / Investigator 9115 Chesapeake Virginia 23320
Site Ref # / Investigator 6674 Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00562887, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 22, 2011 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00562887 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →